Article Text

Download PDFPDF
Campylobacter myocarditis: a rare but potential sequelae of Campylobacter jejuni
  1. Audrey Jia Yin Ang1,
  2. Michael McCann2 and
  3. Paul Stobie3
  1. 1Cardiology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia
  2. 2Cardiology, Fiona Stanley Hospital, Perth, Western Australia, Australia
  3. 3Cardiovascular Medicine, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia
  1. Correspondence to Dr Audrey Jia Yin Ang; aajy.ang{at}


Myocarditis is an inflammatory cardiomyopathy with a diverse range of both infective and non-infective causes. It is an important cause of dilated cardiomyopathy worldwide, with a variable clinical course ranging from a mild self-limiting illness to fulminant cardiogenic shock requiring mechanical circulatory support and cardiac transplantation. Here, we describe a case of acute myocarditis secondary to Campylobacter jejuni infection in a man in his 50s who presented with an acute coronary syndrome following a recent gastrointestinal illness.

  • Cardiovascular medicine
  • Pericardial disease
  • Infection (gastroenterology)

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Contributors The following authors were responsible for drafting of the text, sourcing and editing of clinical images, investigation results, drawing original diagrams and algorithms, and critical revision for important intellectual content: AJYA, MM and PS. The following authors gave final approval of the manuscript: AJYA, MM and PS.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.